Celltrion
068270.KS
#681
Rank
ยฃ26.99 B
Marketcap
ยฃ118.37
Share price
-0.47%
Change (1 day)
30.40%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): ยฃ2.48

According to Celltrion 's latest financial reports the company's current EPS (TTM) is ยฃ2.43. In 2022 the company made an earnings per share (EPS) of ยฃ2.17 a decrease over its 2021 EPS that were of ยฃ2.58.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)ยฃ2.4814.25%
2022ยฃ2.17-15.84%
2021ยฃ2.5812.77%
2020ยฃ2.2970.79%
2019ยฃ1.3415.63%
2018ยฃ1.16-33.13%
2017ยฃ1.73141.17%
2016ยฃ0.728.28%
2015ยฃ0.6611.28%
2014ยฃ0.6016.37%
2013ยฃ0.51-67.42%
2012ยฃ1.5784.22%
2011ยฃ0.8562.13%
2010ยฃ0.5380.61%
2009ยฃ0.29-559.63%
2008-ยฃ0.06351-123.16%
2007ยฃ0.27